Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal Steroids for CCAM
NCT00670956Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Apr 2008
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of betamethasone in congenital pulmonary airway malformation (CPAM), sponsored by University of California, San Francisco. Started Apr 2008; status: terminated.
02
Drugs
betamethasone
03
Conditions
congenital pulmonary airway malformation (CPAM)
Beyond the preview
Go deeper on NCT00670956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670956.